Helmerich & Payne downgraded to In Line from Outperform at Evercore ISI
Evercore ISI analyst Jason Bandel downgraded Helmerich & Payne to In Line from Outperform with a price target of $39, down from $48. The ...
Labcorp upgraded to Outperform from In Line at Evercore ISI
Evercore ISI upgraded Labcorp (LH) to Outperform from In Line with a price target of $265, up from $260. The firm sees upside to consensus EPS ...